Table 1.

Participants with HSV-2 infection studied in this report

Participant characteristic	Value for:
	CD4 study (n = 67)	pDC study (n = 40)
White race [n (%)]	58 (87)	36 (90)
Men [n (%)]	31 (46)	23 (58)
HSV-1/HSV-2 seropositive [n (%)]	30 (45)	20 (50)
CMV seropositive [n (%)]	17/26 (65)	UNKa
Age at shedding session (yr) [(median (range)]	43 (20 to 70)	43 (23 to 62)
History of symptoms [n (%)]	52 (78)	32 (80)
Yr since acquired [median (range)]	12.7 (0.1 to 37.8)	10.6 (0.2 to 34.2)
Yr between shedding session and blood draw [median (range)]	0.8 (−2.0 to 13.6)	9.0 (0.3 to 20.3)
Overall shedding rate [positive swabs/swabs collected (%)]	664/4,070 (16)	438/2,326 (19)
Overall lesion rate [lesional days/days with diary (%)]	486/4,396 (11)	331/2,630 (13)

^aUNK, unknown.